November 30, 2016 / 12:20 PM / a year ago

BRIEF-Fitch says revised its outlook for global pharma sector to stable from negative

Nov 30 (Reuters) - Fitch:

* Fitch says revised its outlook for global pharma sector to stable from negative

* Good pace of new drug approvals is expected to continue during 2017, with a particular focus on biologic agents

* Change reflects anticipated good research and development productivity, manageable patent expiries and a declining degree of event risk

* Expect global pharma players to continue to have strong investment-grade credit profiles

* Expects focus on value in healthcare to increase as currently observed in intensifying debate around drug pricing

* Key near-term risks to global pharma sector outlook lie in more aggressive implementation of healthcare economics leading to greater political risks

* Expect sector’s underlying long-term drivers to remain stable Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below